Evidence map›Paper›PMID 28176244›Full record

ArticleMolecular and cellular biochemistry2017

Cytotoxic effects of the cardenolide convallatoxin and its Na,K-ATPase regulation.

Naira Fernanda Zanchett Schneider, Izabella Thais Silva, Lara Persich, Annelise de Carvalho, Sayonarah C Rocha, Lucas Marostica, Ana Carolina Pacheco Ramos, Alex G Taranto, Rodrigo M Pádua, Wolfgang Kreis and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Naira Fernanda Zanchett SchneiderDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina (UFSC), LVA, CIF, CCS, Florianópolis,, SC, 88040-900, Brazil.
Izabella Thais SilvaDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina (UFSC), LVA, CIF, CCS, Florianópolis,, SC, 88040-900, Brazil.
Lara PersichDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina (UFSC), LVA, CIF, CCS, Florianópolis,, SC, 88040-900, Brazil.
Annelise de CarvalhoDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina (UFSC), LVA, CIF, CCS, Florianópolis,, SC, 88040-900, Brazil.
Sayonarah C RochaLaboratório de Bioquímica Celular, Campus Centro-Oeste Dona Lindu, Universidade Federal de São João del Rei, Divinopolis, MG, Brazil.
Lucas MarosticaDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina (UFSC), LVA, CIF, CCS, Florianópolis,, SC, 88040-900, Brazil.
Ana Carolina Pacheco RamosLaboratório de Bioquímica Celular, Campus Centro-Oeste Dona Lindu, Universidade Federal de São João del Rei, Divinopolis, MG, Brazil.
Alex G TarantoLaboratório de Bioinformática, Campus Centro Oeste Dona Lindu, Universidade Federal de São João Del Rei, Divinópolis, MG, Brazil.
Rodrigo M PáduaDepartamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Wolfgang KreisDepartment of Biology, Friedrich-Alexander Universität, Erlangen, Germany.
Leandro A BarbosaLaboratório de Bioquímica Celular, Campus Centro-Oeste Dona Lindu, Universidade Federal de São João del Rei, Divinopolis, MG, Brazil.
Fernão C BragaDepartamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Cláudia M O SimõesDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina (UFSC), LVA, CIF, CCS, Florianópolis,, SC, 88040-900, Brazil. claudia.simoes@ufsc.br.
Universidade Federal de Santa Catarina · BRFederal University of São João del-Rei · BRUniversidade Federal de Minas Gerais · BRFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardenolides are cardiac glycosides, mostly obtained from natural sources. They are well known for their inhibitory action on the Na,K-ATPase, an effect that regulates cardiovascular alterations such as congestive heart failure and atrial arrhythmias. In recent years, they have also sparked new interest in their anticancer potential. In the present study, the cytotoxic effects of the natural cardenolide convallatoxin (CON) were evaluated on non-small cell lung cancer (A549 cells). It was found that CON induced cytostatic and cytotoxic effects in A549 cells, showing essentially apoptotic cell death, as detected by annexin V-propidium iodide double-staining, as well as changes in cell form. In addition, it prompted cell cycle arrest in G2/M and reduced cyclin B1 expression. This compound also increased the number of cells in subG1 in a concentration- and time-dependent manner. At a long term, the reduction of cumulative population doubling was shown along with an increase of β-galactosidase positive cells and larger nucleus, indicative of senescence. Subsequently, CON inhibited the Na,K-ATPase in A549 cells at nM concentrations. Interestingly, at the same concentrations, CON was unable to directly inhibit the Na,K-ATPase, either in pig kidney or in red blood cells. Additionally, results of docking calculations showed that CON binds with high efficiency to the Na,K-ATPase. Taken together, our data highlight the potent anticancer effects of CON in A549 cells, and their possible link with non-classical inhibition of Na,K-ATPase.

Indexed as

A549 CellsAnimalsAntineoplastic Agents, PhytogenicApoptosisCarcinoma, Non-Small-Cell LungCell ProliferationCell SurvivalDose-Response Relationship, DrugErythrocytesG2 Phase Cell Cycle CheckpointsHumansKidneyLung NeoplasmsMolecular Docking SimulationSodium-Potassium-Exchanging ATPaseStrophanthinsAntineoplastic Agents, PhytogenicconvallatoxinSodium-Potassium-Exchanging ATPaseStrophanthinsA549 cellsApoptosisCardenolidesConvallotoxin ConvallatoxinCytotoxic effectsNa,K-ATPase

Identifiers

PMID28176244
OpenAlexW2587009424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.